StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) stock

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.41+0.05 (+13.12%)

Close on Nov 18, 2026Market cap $99.30MP/E –Yield –

Outlook Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Outlook Therapeutics's market cap was $89.99M on Nov 11, 2026, against $96.46M a year earlier. Over the last 5 years it ranged from $13.29M to $446.60M, with a median of $124.92M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$89.99M+5.7%
2025Dec 31, 2025$85.14M+88.4%
2024Dec 31, 2024$45.18M-55.9%
2023Dec 29, 2023$102.54M-58.2%
2022Dec 30, 2022$245.50M+2.3%
2021Dec 31, 2021$239.99M+45.1%
2020Dec 31, 2020$165.34M+879.5%
2019Dec 31, 2019$16.88M-53.3%
2018Dec 31, 2018$36.11M+11.4%
2017Dec 29, 2017$32.41M-52.8%
2016Dec 30, 2016$68.64M–

More Outlook Therapeutics figures

See a number that looks wrong?